CNS Disorders  >>  memantine  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
memantine / Generic mfg.
NCT03316898: A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease

Withdrawn
1b
0
US
AGN-242071, Placebo, Donepezil, Memantine
Allergan
Alzheimer's Disease
11/18
11/18
NCT00829816: Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil

Completed
1
46
US
Dimebon, Placebo
Medivation, Inc.
Alzheimer's Disease
04/09
08/10

Download Options